CVS Health Corp. (CVS) Financials
CVS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 253.8 billion | 173.9 billion |
| March 31, 2026 | 253.0 billion | 175.3 billion |
| Dec. 31, 2025 | 261.1 billion | 185.7 billion |
| Sept. 30, 2025 | 255.3 billion | 182.2 billion |
CVS Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 5.7 billion | 176.0 million |
| March 31, 2026 | 3.4 billion | 266.0 million |
| Dec. 31, 2025 | 2.6 billion | 135.0 million |
| Sept. 30, 2025 | 98.0 million | -126.0 million |
CVS Net Income
| Date | Net Income |
|---|---|
| June 30, 2026 | 3.0 billion |
| March 31, 2026 | 3.0 billion |
| Dec. 31, 2025 | 2.9 billion |
| Sept. 30, 2025 | -2.8 billion |
CVS Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 14.0 billion | 59.5 billion | 14.9 billion |
| March 31, 2026 | 11.8 billion | 60.5 billion | 15.2 billion |
| Dec. 31, 2025 | 10.7 billion | 72.9 billion | 14.9 billion |
| Sept. 30, 2025 | 11.3 billion | 60.5 billion | 14.0 billion |
CVS Shares Outstanding
CVS Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 691.0 million | - | - | - |
| March 31, 2026 | 849.0 million | - | - | - |
| Dec. 31, 2025 | 784.0 million | - | - | - |
| Sept. 30, 2025 | 698.0 million | - | - | - |
CVS Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 106.1 billion | 90.3 billion |
| March 31, 2026 | 100.4 billion | 84.8 billion |
| Dec. 31, 2025 | 105.7 billion | 92.1 billion |
| Sept. 30, 2025 | 102.9 billion | 89.1 billion |
CVS Revenue by Segment
CVS
Price: $96.74
Dividend Yield: 2.78%
Forward Dividend Yield: 2.75%
Payout Ratio: 47.33%
Dividend Per Share: 2.66 USD
Earnings Per Share: 3.79 USD
P/E Ratio: 25.24
Exchange: NYQ
Sector: Healthcare
Industry: Healthcare Plans
Country: United States
Volume: 7.3 million
Ebitda: 3.7 billionMarket Capitalization: 122.4 billion
Average Dividend Frequency: 4
Years Paying Dividends: 42
DGR3: 7.41%
DGR5: 5.95%
DGR10: 7.47%
DGR20: 16.45%